You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
愛康醫療(01789.HK)年度純利增長17.6%至3.14億元 末期息4港仙
格隆匯 03-22 21:27

格隆匯3月22日丨愛康醫療(01789.HK)發佈公吿,截至2020年12月31日止年度,公司收入10.35億元人民幣,同比增長11.7%;毛利7.145億元,同比增長11.1%;公司擁有人應占溢利3.14億元,同比增長17.6%;每股盈利0.28元,末期股息每股股份4.0港仙。

集團在疫情影響下仍能保持收入的增長主要得益於公司藉助已樹立了品牌形象及市場領導地位,有效地推動了關節產品的銷售所致。

2020年,由於境外疫情和政策等不確定性因素影響,集團收購JRI形成的商譽出現減值跡象。集團對收購JRI形成的商譽計提了減值準備880萬元。扣除2020年商譽減值影響,以及扣除2019年來自JRI的一次性的保險賠償收入後,集團截至2020年12月31日止年度的淨利潤較2019年顯著增加27.0%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account